Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.
about
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disordersModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionEarly Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementDeletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehaviorNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in miceMolecular Targets of Cannabidiol in Neurological DisordersCannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives.Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.Melatonin Alleviates Liver Apoptosis in Bile Duct Ligation Young Rats.Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors.Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New AgeCannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
P2860
Q24623179-0B7D4B8A-BD05-4C45-A1E5-9BB5BD405AE8Q27014154-938E9509-E3A8-4813-A3A6-ADECA4F5421FQ27336497-5FBB9CB7-3F0B-493D-9475-250BF436882FQ28394506-96D89810-81CC-4560-88B4-3C1BECC506DCQ30633123-BA4400EF-4E60-4DD9-B269-7A6BB0CC4A6CQ34143222-A8733F20-5483-42D8-8FC8-C8A2FA76EEC6Q34336645-454653DD-CF5A-42CD-B282-520687D5D121Q34557613-33DCA460-2C89-4D80-BEA5-BF96F13E5988Q34625932-8A808FCE-630E-43E8-8449-B575D43166F2Q34672113-AFFCEF85-5C7C-46BC-9F71-B9663BD346ACQ36157649-DF570CBB-6334-4618-A1E5-2CE4CD099840Q36176491-F5D867A3-E34C-49A9-A635-CFC34A934EA3Q37029990-ABD88C8A-806E-46DC-89C0-C22CC33C725FQ37399902-CE6264CF-368C-41DF-9CDF-B6C78F52A234Q38012845-872A1035-E99D-4ADE-9F83-195C989A6D23Q38124458-D769B44B-09ED-4D81-B86D-18560A1F8219Q38194626-57451F92-EFB7-40E5-AA01-82B2C18479F3Q38974387-4AB21C0C-1CB7-4001-BCF5-66EDD86EFC61Q40952998-E95FB797-A960-41AB-A4EC-5B2F6EBFDCA8Q43217955-CB09FB6D-E79D-4C25-B60F-CB2AFF8790AAQ44128178-6EB13C8D-CEFF-4E97-9B1E-4CD4EA66DEF5Q47963305-DA0DBA31-112C-48DD-BC04-28B9DEB29F45Q50654164-F6319732-1813-46F3-8258-0A6F36E8CE82Q57300019-5F49D352-4567-4936-A581-FDCC13E40F29Q58727916-A0DD10F4-856C-42C9-91DD-ECA7E9DBBB4E
P2860
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@ast
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@en
type
label
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@ast
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@en
prefLabel
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@ast
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@en
P2093
P2860
P1476
Cannabidiol ameliorates cognit ...... ia 5-HT1A receptor activation.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2009.00589.X
P407
P577
2010-01-29T00:00:00Z